In summary, we provide new insight and understanding into the role a distinct population of GLP-1R expressing neurones in the brain, an area of timely translational importance, as these receptors are drug targets for treatment of metabolic diseases and new combinational therapies are being formulated to improve treatment regimens. Here, GLP1R is linked to metabolic disease.